BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Lecigon (Trigel) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Lecigon (Trigel)\, from ClinicalTrials.go
 v estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07151378-1675@assetmemo.bio
DTSTAMP:20261121T004448Z
DTSTART;VALUE=DATE:20300922
DTEND;VALUE=DATE:20300923
SUMMARY:Lecigon (Trigel): Phase 3 readout est. (NCT07151378)
DESCRIPTION:Lecigon (Trigel)\, phase 3\, Parkinson's Disease.\nStudy: Intes
 tinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic
  Desensitization and Neuropsychiatric Complications in Parkinson's Disease
 \nEstimated primary completion: 22 September 2030. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/trigel#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT07151378
URL:https://assetmemo.bio/drug/trigel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
